Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
Circulation: Cardiovascular Quality and Outcomes · 2023
DOI: 10.1161/circoutcomes.123.010034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2023. Verfasst von Mabel Chung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (M.C.). Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Heart Valve Prosthesis Implantation, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Days at home (DAH) represents an important patient-oriented outcome that quantifies time spent at home after a medical event; however, this outcome has not been fully evaluated for low-surgical-risk patients undergoing transcatheter aortic valve replacement (TAVR). We sought to compare 1- and 2-year DAH (DAH 365 and DAH 730 ) among low-risk patients participating in a randomized trial of TAVR with a self-expanding bioprosthesis versus surgical aortic valve replacement (SAVR). METHODS: Using Medicare-linked data from the Evolut Low Risk trial, we identified 619 patients: 606 (322 TAVR/284 SAVR) and 593 (312 TAVR/281 SAVR) were analyzed at 1 and 2 years, respectively. DAH was calculated as days alive and spent outside a hospital, inpatient rehabilitation, skilled nursing facility, long-term acute care hospital, emergency department, or observation stay. Mean DAH was compared using the t test. RESULTS: The mean (SD) age and female sex were 74.7 (5.1) and 74.3 (4.9) years and 34.6% (115/332) and 30.3% (87/287) in TAVR and SAVR, respectively. Postprocedural discharge to rehabilitation occurred in ≤3.0% (≤10/332) in TAVR and 4.5% (13/287) in SAVR. The mean DAH 365 was comparable in TAVR versus SAVR (352.2±45.4 versus 347.8±39.0; difference in days, 4.5 [95% CI, 2.3–11.2]; P =0.20). DAH 730 was also comparable in TAVR versus SAVR (701.6±106.0 versus 699.6±94.5; difference in days, 2.0 [−14.1 to 18.2]; P =0.81). Secondary outcomes DAH 30 and DAH 90 were higher in TAVR (DAH 30 , 26.0±3.6 versus 20.7±6.4; difference in days, 5.3 [4.5–6.2]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (M.C.).
- Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.).
- Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (Z.I.A.).
- Division of Cardiovascular Medicine, Department of Medicine, (J.X., Y.S., D.S.K., R.W.Y.), Beth Israel Deaconess Medical Center, Boston, MA.
- Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA (S.J.B.).
- Baim Institute for Clinical Research, Boston, MA (S.J.B.).
ORCID-Profile: Mabel Chung, Zaid I Almarzooq, Suzanne J Baron, Dhruv S Kazi, Robert W Yeh
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Chung, M., Almarzooq, Z. I., Xu, J., Song, Y., Baron, S. J., Kazi, D. S., & Yeh, R. W. (2023). Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.123.010034
Vancouver
Chung M, Almarzooq ZI, Xu J, Song Y, Baron SJ, Kazi DS, et al. Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Circulation: Cardiovascular Quality and Outcomes. 2023. doi:10.1161/circoutcomes.123.010034
BibTeX
@article{Chung2023,
author = {Chung, Mabel and Almarzooq, Zaid I and Xu, Jiaman and Song, Yang and Baron, Suzanne J and Kazi, Dhruv S and Yeh, Robert W},
title = {Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2023},
doi = {10.1161/circoutcomes.123.010034}
}
EUVIMED